Compound

Thymosin

A family of small peptides originally isolated from thymus tissue that regulate immune function, cellular migration, and tissue repair.

Definition

Thymosin is a family of small peptides originally isolated from thymic tissue by Goldstein and colleagues in the 1960s and 1970s. The family encompasses multiple alpha and beta thymosin fractions with distinct biological properties. Thymosin Alpha-1 (28 amino acids) is the primary immunomodulatory member, studied for its role in T-cell differentiation and innate immune activation through TLR-9 signaling. Thymosin Beta-4 (43 amino acids) and its active fragments (including TB-500) are studied primarily for their actin-sequestration activity and roles in cellular migration, wound healing, and cardiac repair. The two thymosin subfamilies have largely distinct biological profiles despite sharing a common tissue of origin and naming convention.

Research Context

The thymosin family is well represented in research peptide science. Thymosin Alpha-1 is studied for immune modulation in infection and tumor immunology research models. Thymosin Beta-4 and TB-500 are studied for tissue repair and angiogenesis in wound healing, cardiac, and musculoskeletal research. Understanding that the alpha and beta thymosin subfamilies are functionally distinct prevents confusion when interpreting research literature. The research compound portfolios and preclinical evidence bases for these two subfamilies are substantially different.

Relevant Compounds

This term applies to the following research compound hubs.

Frequently Asked Questions

Explore the Research Library

Compound comparisons, research use cases, study indexes, and more. A complete reference for research-grade peptide science.